We’re using cutting-edge machine learning models to determine the potential of particular entities. This way you gain access to the most recent market insight, and you can follow the dynamics of the changing potential and your relative position.
Set your marketing strategy in the context of the brand, entities and activities on the pharmaceutical market. We created segmentation 3.0 on the basis of machine learning and you can easier set sales plans, monitor the potential and its changes.
Plan visits precisely
Set your marketing strategy in the context of your brand, entities and activities on the pharmaceutical market. Thanks to Segmentation 3.0, created on the basis of machine learning, you will find it easier to set sales plans, monitor the potential and its changes. You will also measure the effectiveness of implemented marketing activities and dedicated tools for entities with high potential and low share of own (producer) sales.
COMPREHENSIVE DATA SOURCE
Choosing segmentation 3.0 gives you:
The potential of every entity in Poland including brick and mortar pharmacies, as well as online pharmacies (e-commerce channel) – regarding OTC products.
The most precise segmentation on the pharmaceutical entities market beginning with 2+.
Entities’ potential expressed as percentage and information on any change to that potential.
If you’re a FarmaProm client, you additionally receive information on the share of your own sales and the change of penetration.
It’s a perfect solution for:
identifying entities / pharmacies with high sales potential that your representatives haven’t visited so far.
allocating entities with highest potential to network channels and those with lower potential to the other channels of distribution.
Be up to date with your performance and sales results.
Value for money
Selecting monthly subscription translates into low unit costs, which in turn means savings for your company.
You get a full set of data at the beginning of every month.
You will receive analysis that’s based on the most recent pharmaceutical market data.
Monitor Polish pharmaceutical markets on a regular basis end track changes to entities’ potential.